| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.5 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |